EP3076972A4

Cancer treatment with combination of plinabulin and taxane

Abstract

This record has no abstract on file.

EP3076972A4, drawing sheet 1 — Sheet 1 of 13

Term

7 yearsto projected expiry

Projected expiry 11 October 2033, counted from filing; an application has no term until it is granted.

13 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10
Sheet 11
Sheet 12
Sheet 13

Every citation, both ways

Citations
Reference	Relation	Cited during
A. C. MITA ET AL: "Phase II study of docetaxel with or without plinabulin (NPI-2358) in patients with non-small cell lung cancer (NSCLC).", JOURNAL OF CLINICAL ONCOLOGY, vol. 28, no. 15_suppl, 20 May 2010 (2010-05-20), US, pages 7592 - 7592, XP055394409, ISSN: 0732-183X, DOI: 10.1200/jco.2010.28.15_suppl.7592	Non-patent	Search report

33 members in 18 offices

This recordMember, by publication date8 more offices are in the list below

Members33

Family members, oldest first
Document	Office	Kind
CA2926771A1	Canada	A1	2015-04-16
WO2015051543A1	World Intellectual Property Organization (WIPO)	A1	2015-04-16
WO2015051543A8	World Intellectual Property Organization (WIPO)	A8	2016-04-21
AU2013402794A1	Australia	A1	2016-05-12
SG11201602637QA	Singapore	A	2016-05-30
IL244984A0	Israel	A0	2016-05-31
IL244984D0	Israel	D0	2016-05-31
CN105705148A	China	A	2016-06-22
KR20160078987A	Republic of Korea	A	2016-07-05
US2016250209A1	United States of America	A1	2016-09-01
EP3076972A1	European Patent Office (EPO)	A1	2016-10-12
MX2016004441A	Mexico	A	2016-10-28
JP2016536352A	Japan	A	2016-11-24
BR112016007946A2	Brazil	A2	2017-09-12
RU2016112608A	Russian Federation	A	2017-11-16
EP3076972A4This record	European Patent Office (EPO)	A4	2017-12-20
RU2662298C2	Russian Federation	C2	2018-07-25
JP6411523B2	Japan	B2	2018-10-24
AU2013402794B2	Australia	B2	2020-02-27
US10596169B2	United States of America	B2	2020-03-24
NZ719049A	New Zealand	A	2020-06-26
US2020281921A1	United States of America	A1	2020-09-10
KR102225371B1	Republic of Korea	B1	2021-03-10
CN105705148B	China	B	2021-03-23
MY185650A	Malaysia	A	2021-05-27
EP3076972B1	European Patent Office (EPO)	B1	2021-10-06
DK3076972T3	Denmark	T3	2022-01-03
ES2902665T3	Spain	T3	2022-03-29
IL244984A	Israel	A	2022-05-01
IL244984B	Israel	B	2022-05-01
ZA201602380B	South Africa	B	2022-05-25
CA2926771C	Canada	C	2022-07-05
MX384751B	Mexico	B	2025-03-14

88 legal events, as 13 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2026-07-29	Ip right maintained in amended form following an ip right review or an appealAppealST27 STATUS EVENT CODE: U-0-0-M10-M12 (AS PROVIDED BY THE NATIONAL OFFICE)M12	M12	CH
2026-07-24	Patent maintained in amended formORIGINAL CODE: 0009272PUAH	PUAH	EP
2026-07-24	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT MAINTAINED AS AMENDEDSTAA	STAA	EP
2026-01-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-01-19	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-01-14	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-01-12	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-01-08	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-12-12	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2025-11-01	Full renewal or maintenance fee paidST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)U11	U11	CH
2025-10-22	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-10-21	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-10-20	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-10-16	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-10-16	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-10-15	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-10-15	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-10-06	Examination report in opposition despatched + time limitOppositionORIGINAL CODE: EPIDOSNORE2PLAY	PLAY	EP
2025-07-29	Appeal procedure closedAppealORIGINAL CODE: EPIDOSNNOA9OAPBU	APBU	EP
2024-09-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-07-16	Date of receipt of statement of grounds of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA3OAPBQ	APBQ	EP
2024-06-11	Appeal reference modifiedAppealORIGINAL CODE: EPIDOSCREFNOAPAH	APAH	EP
2024-06-11	Appeal reference deletedAppealORIGINAL CODE: EPIDOSDREFNOAPAW	APAW	EP
2024-05-15	Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP	APBP	EP
2024-04-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2024-04-10	Communication despatched that opposition was rejectedOppositionORIGINAL CODE: EPIDOSNREJ1PLCK	PLCK	EP
2023-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2023-06-21	Opt-out of the competence of the unified patent court (upc) registeredP01	P01	EP
2023-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-11-30	Reply of patent proprietor to notice(s) of opposition receivedOppositionORIGINAL CODE: EPIDOSNOBS3PLBB	PLBB	EP
2022-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-08-17	Opposition filedOpposition26	26	EP
2022-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-07-19	Notice of opposition and request to file observation + time limit sentOppositionORIGINAL CODE: EPIDOSNOBS2PLAX	PLAX	EP
2022-07-15	Opposition filedOppositionORIGINAL CODE: 0009260PLBI	PLBI	EP
2022-07-06	Opposition filed against patentOppositionR026	R026	DE
2022-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-06-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-04-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-04-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-04-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-04-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-04-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2022-03-29	Definitive protectionFG2A	FG2A	ES
2022-03-15	Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05	MK05	AT
2022-03-07	Entry of ep patent into national phase of norway [publ. of translation]T2	T2	NO
2022-01-26	Translation for ep filed (entry of ep into country)FP	FP	NL
2022-01-25	Invalidation of extension of european patentsMG9D	MG9D	LT
2022-01-03	Ep patent with danish claimsT3	T3	DK
2021-12-28	Translation of granted ep patentGrantedTRGR	TRGR	SE
2021-10-27	European patents granted designating irelandGrantedFG4D	FG4D	IE
2021-10-21	Dpma publication of mentioned ep patent grantGrantedR096	R096	DE
2021-10-15	European patent takes effect as a national patent in ch/liEP	EP	CH
2021-10-15	Reference to at number (ep patent validated in austria)REF	REF	AT
2021-10-06	Designated contracting statesAK	AK	EP
2021-10-06	European patent grantedGrantedFG4D	FG4D	GB
2021-09-03	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2021-09-03	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA	STAA	EP
2021-08-30	Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS	GRAS	EP
2021-06-02	Intention to grant announcedINTG	INTG	EP
2021-05-03	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP	GRAP	EP
2021-05-03	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA	STAA	EP
2019-09-18	First examination report despatched17Q	17Q	EP
2019-08-16	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: EXAMINATION IS IN PROGRESSSTAA	STAA	EP
2017-12-20	Supplementary search report drawn up and despatchedA4	A4	EP
2017-12-20	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2017-12-20	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2017-12-20	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2017-11-24	Requests to designate patent in hong kongDE	DE	HK
2017-09-06	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2017-09-06	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2017-09-06	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2017-01-18	Request for extension of the european patent (deleted)DAX	DAX	EP
2016-10-12	Request for examination filed17P	17P	EP
2016-10-12	Designated contracting statesAK	AK	EP
2016-10-12	Request for extension of the european patentAX	AX	EP
2016-09-09	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

Cancer treatment with combination of plinabulin and taxane

Abstract

Term

Members33

Over the term

Events

Numbers

Titles3

Classification

Designated states38